Sludge, stones and sickle cell anaemia

A A Olatunji1, P O Olatunji

  • 1Department of Radiology, University of Ilorin Teaching Hospital, Ilorin.

Insights

Sickle cell anaemia patients often develop gallbladder sludge and stones, with prevalence increasing with age and disease severity. These findings highlight the need for closer monitoring in at-risk individuals.

Area of Science:

  • Medical research
  • Hepatobiliary system
  • Hematology

Background:

  • Sickle cell anaemia is a genetic blood disorder associated with various complications.
  • Gallbladder abnormalities, including stones and sludge, are potential complications in sickle cell disease patients.
  • Previous studies have indicated a higher risk of gallstones in sickle cell anaemia patients.

Purpose of the Study:

  • To investigate the prevalence and characteristics of gallbladder stones and sludge in patients with sickle cell anaemia.
  • To determine the influence of patient age, packed cell volume (PCV), and number of crises per year on the development of gallbladder abnormalities.
  • To compare gallbladder content in sickle cell anaemia patients with healthy control subjects.

Main Methods:

  • Ultrasonographic examination of gallbladder contents was performed on 97 sickle cell anaemia patients and 48 controls.
  • Patient data including age, PCV, and number of crises per year were collected.
  • Subjects were categorized based on the presence or absence of gallbladder stones and/or sludge.

Main Results:

  • 70 patients had normal gallbladder content, 18 had sludge, 6 had stones, and 3 had both.
  • No sludge or stones were observed in the control group.
  • Gallbladder abnormalities (sludge and stones) were more prevalent in older patients and those with higher crisis frequency.
  • PCV and crisis frequency differentiated between normal and abnormal gallbladder contents.

Conclusions:

  • A high prevalence of gallbladder sludge was observed in sickle cell anaemia patients.
  • Age and disease activity (number of crises) are associated with the development of gallbladder stones and sludge.
  • These findings suggest a need for increased surveillance and monitoring of gallbladder health in sickle cell anaemia patients.
  • Further research with larger cohorts is warranted to confirm these associations and identify patients requiring closer management.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...